10x Genomics Ownership 2024 | Who Owns 10x Genomics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

29.66%

Insider Ownership

2.18%

Retail Ownership

68.17%

Institutional Holders

127.00

10x Genomics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC10.90%0.02%13,010,50981,2600.63%253,054,393Jun 30, 2024
VANGUARD GROUP INC8.53%0.00%10,189,2571,087,72111.95%198,181,048Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC7.80%1.61%9,313,7633,029,95148.22%181,152,698Jun 30, 2024
BLACKROCK INC.5.35%0.00%6,392,650385,0076.41%124,337,031Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.5.15%1.38%6,148,2522,526,47469.76%119,337,571Jun 30, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.5.15%0.09%6,143,0672,521,28969.61%119,482,653Jun 30, 2024
MORGAN STANLEY4.84%0.01%5,773,868609,36111.80%112,301,758Jun 30, 2024
GENERATION INVESTMENT MANAGEMENT LLP2.42%0.27%2,884,6611,470,537103.99%56,106,656Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.41%0.01%2,873,952-783,275-21.42%55,899,000Jun 30, 2024
BAILLIE GIFFORD & CO2.30%0.04%2,742,153-4,682,613-63.07%53,334,875Jun 30, 2024
BROWN CAPITAL MANAGEMENT LLC2.08%0.98%2,483,705-191,142-7.15%48,308,062Jun 30, 2024
SANDS CAPITAL MANAGEMENT, LLC1.96%0.13%2,334,901-1,048,240-30.98%45,413,824Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.1.81%0.03%2,162,979-41,451-1.88%42,070,000Jun 30, 2024
VENROCK MANAGEMENT VI, LLC1.76%100.00%2,106,757--40,976,424Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC1.61%0.01%1,926,4831,791,8021330.40%37,470,093Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.48%0.00%1,772,933129,7807.90%34,493,188Jun 30, 2024
STATE STREET CORP1.37%0.00%1,634,10948,4073.05%31,783,420,000Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.21%0.10%1,440,042538,29759.70%28,008,817Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.14%0.01%1,360,751228,32320.16%26,466,607Jun 30, 2024
NORGES BANK0.83%0.00%991,051991,051100.00%19,275,942Jun 30, 2024

10x Genomics's largest institutional shareholder is FMR LLC, holding 10.90% of the company's total share outstanding, currently valued at $253.05M. The top 10 institutional shareholders own together 54.84% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VENROCK MANAGEMENT VI, LLC1.76%100.00%2,106,757--40,976,424Jun 30, 2024
BLUE WATER LIFE SCIENCE ADVISORS, LP0.19%4.35%230,00035,50018.25%4,473,500Jun 30, 2024
MERITECH CAPITAL ASSOCIATES V L.L.C.0.41%3.30%494,236--9,612,890Jun 30, 2024
SANDS CAPITAL VENTURES, LLC0.40%3.14%481,770--9,370,427Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC7.80%1.61%9,313,7633,029,95148.22%181,152,698Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.5.15%1.38%6,148,2522,526,47469.76%119,337,571Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.60%1.23%719,000719,000100.00%13,984,550Jun 30, 2024
BROWN CAPITAL MANAGEMENT LLC2.08%0.98%2,483,705-191,142-7.15%48,308,062Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.03%0.54%30,000--583,500Jun 30, 2024
PDT PARTNERS, LLC0.22%0.48%261,880216,662479.15%5,093,566Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.39%0.37%461,013-48,020-9.43%8,966,703Jun 30, 2024
SLOW CAPITAL, INC.0.09%0.33%105,52617,76120.24%2,052,481Jun 30, 2024
NUMERAI GP LLC0.04%0.33%46,55946,559100.00%905,573Jun 30, 2024
PROSIGHT MANAGEMENT, LP0.04%0.28%49,02119,02163.40%953,458Jun 30, 2024
GENERATION INVESTMENT MANAGEMENT LLP2.42%0.27%2,884,6611,470,537103.99%56,106,656Jun 30, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.28%0.26%334,007155,11486.71%6,496,436Jun 30, 2024
SVB WEALTH LLC0.44%0.25%525,044-915,516-63.55%10,212,103Jun 30, 2024
MIRADOR CAPITAL PARTNERS LP0.05%0.23%61,96733,142114.98%1,205,258Jun 30, 2024
ALLEN OPERATIONS LLC0.05%0.22%56,600--1,100,870Jun 30, 2024
BRANDYWINE MANAGERS, LLC0.01%0.21%10,073--195,920Jun 30, 2024

The largest 10x Genomics shareholder by % of total assets is VENROCK MANAGEMENT VI, LLC. The company owns 2.11M shares of 10x Genomics (TXG), representing 100.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARK INVESTMENT MANAGEMENT LLC7.80%1.61%9,313,7633,029,95148.22%181,152,698Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.5.15%1.38%6,148,2522,526,47469.76%119,337,571Jun 30, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.5.15%0.09%6,143,0672,521,28969.61%119,482,653Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC1.61%0.01%1,926,4831,791,8021330.40%37,470,093Jun 30, 2024
GENERATION INVESTMENT MANAGEMENT LLP2.42%0.27%2,884,6611,470,537103.99%56,106,656Jun 30, 2024
VANGUARD GROUP INC8.53%0.00%10,189,2571,087,72111.95%198,181,048Jun 30, 2024
NORGES BANK0.83%0.00%991,051991,051100.00%19,275,942Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.60%1.23%719,000719,000100.00%13,984,550Jun 30, 2024
MORGAN STANLEY4.84%0.01%5,773,868609,36111.80%112,301,758Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.50%0.19%597,000597,000100.00%11,611,650Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.21%0.10%1,440,042538,29759.70%28,008,817Jun 30, 2024
SRS INVESTMENT MANAGEMENT, LLC0.42%0.13%504,257504,257100.00%9,807,799Jun 30, 2024
BARCLAYS PLC0.44%0.00%521,957464,221804.04%10,152,000Jun 30, 2024
BLACKROCK INC.5.35%0.00%6,392,650385,0076.41%124,337,031Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.52%0.02%620,002236,29861.58%12,059,039Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.14%0.01%1,360,751228,32320.16%26,466,607Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.26%0.01%315,180219,945230.95%6,130,251Jun 30, 2024
PDT PARTNERS, LLC0.22%0.48%261,880216,662479.15%5,093,566Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.18%0.01%210,200157,800301.14%4,088,390Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.15%0.01%181,148157,386662.34%3,523,323Jun 30, 2024

As of Jun 30 2024, 10x Genomics's largest institutional buyer is ARK INVESTMENT MANAGEMENT LLC. The company purchased 3.03M stocks of TXG, valued at $181.15M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAILLIE GIFFORD & CO2.30%0.04%2,742,153-4,682,613-63.07%53,334,875Jun 30, 2024
RTW INVESTMENTS, LP0.42%0.15%502,856-1,052,000-67.66%9,780,549Jun 30, 2024
SANDS CAPITAL MANAGEMENT, LLC1.96%0.13%2,334,901-1,048,240-30.98%45,413,824Jun 30, 2024
SVB WEALTH LLC0.44%0.25%525,044-915,516-63.55%10,212,103Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.41%0.01%2,873,952-783,275-21.42%55,899,000Jun 30, 2024
FRESHFORD CAPITAL MANAGEMENT, LLC----783,238-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC0.10%0.00%122,304-758,860-86.12%2,378,813Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.----706,492-100.00%-Jun 30, 2024
FIRST TRUST ADVISORS LP0.01%0.00%10,093-569,791-98.26%196,308Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.27%0.00%328,181-522,634-61.43%6,383,111Jun 30, 2024
GILDER GAGNON HOWE & CO LLC0.02%0.01%24,394-479,780-95.16%474,463Jun 30, 2024
AMERIPRISE FINANCIAL INC0.05%0.00%60,561-405,793-87.01%1,177,912Jun 30, 2024
FRED ALGER MANAGEMENT, LLC0.06%0.01%65,973-379,594-85.19%1,283,175Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----365,322-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC0.07%0.00%77,850-320,601-80.46%1,514,183Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----319,287-100.00%-Jun 30, 2024
SOUTHPOINT CAPITAL ADVISORS LP0.34%0.19%400,000-300,000-42.86%7,780,000Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.18%0.00%215,092-261,145-54.84%4,185,096Jun 30, 2024
ORBIMED ADVISORS LLC----225,200-100.00%-Jun 30, 2024
DECHENG CAPITAL LLC----195,835-100.00%-Jun 30, 2024

As of Jun 30 2024, 10x Genomics's biggest institutional seller is BAILLIE GIFFORD & CO. The company sold -4.68M shares of TXG, valued at $53.33M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK0.83%0.00%991,051991,051100.00%19,275,942Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.60%1.23%719,000719,000100.00%13,984,550Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.50%0.19%597,000597,000100.00%11,611,650Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.12%0.01%141,713141,713100.00%2,756,318Jun 30, 2024
HSBC HOLDINGS PLC0.08%0.00%91,33591,335100.00%1,797,473Jun 30, 2024
NUMERAI GP LLC0.04%0.33%46,55946,559100.00%905,573Jun 30, 2024
QUADRATURE CAPITAL LTD0.04%0.01%42,75542,755100.00%830,302Jun 30, 2024
STEEL PEAK WEALTH MANAGEMENT LLC0.02%0.02%21,24721,247100.00%413,255Jun 30, 2024
TWINBEECH CAPITAL LP0.02%0.01%19,01519,015100.00%369,842Jun 30, 2024
BARCLAYS PLC0.01%0.00%17,50017,500100.00%340,000Jun 30, 2024
PINEBRIDGE INVESTMENTS, L.P.0.01%0.00%17,26617,266100.00%335,824Jun 30, 2024
IQ EQ FUND MANAGEMENT (IRELAND) LTD0.01%0.02%11,08111,081100.00%215,525Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.01%0.00%10,97010,970100.00%213,367Jun 30, 2024
COUNTERPOINT MUTUAL FUNDS LLC0.01%0.05%10,86110,861100.00%211,246Jun 30, 2024
FEDERATED HERMES, INC.0.01%0.00%7,0007,000100.00%136,150,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.00%0.00%1,6511,651100.00%32,112Jun 30, 2024
CLEARSTEAD ADVISORS, LLC0.00%0.00%1,2671,267100.00%24,644Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.01%1,1001,100100.00%21,395Jun 30, 2024
VERSANT CAPITAL MANAGEMENT, INC0.00%0.00%205205100.00%3,987Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.00%-127127100.00%2,470Jun 30, 2024
OPTIVER HOLDING B.V.0.00%-121121100.00%2,353Jun 30, 2024
HEXAGON CAPITAL PARTNERS LLC0.00%0.00%106106100.00%2,062Jun 30, 2024
SACHETTA, LLC0.00%0.00%9191100.00%1,858Jun 30, 2024
PICTON MAHONEY ASSET MANAGEMENT0.00%-6363100.00%1,000Jun 30, 2024
INNEALTA CAPITAL, LLC-0.00%5353100.00%1,031Jun 30, 2024
ASSET DEDICATION, LLC-0.00%5151100.00%992Jun 30, 2024
CAPE INVESTMENT ADVISORY, INC.-0.00%5050100.00%973Jun 30, 2024
ADVISORNET FINANCIAL, INC-0.00%4545100.00%875Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC--2929100.00%564Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC-0.00%2626100.00%506Jun 30, 2024
CVA FAMILY OFFICE, LLC-0.00%2323100.00%447Jun 30, 2024
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.-0.00%1212100.00%232Jun 30, 2024
MATHER GROUP, LLC.--44100.00%150Jun 30, 2024

10x Genomics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 991.05K shares, valued at $19.28M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRESHFORD CAPITAL MANAGEMENT, LLC----783,238-100.00%-Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.----706,492-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----365,322-100.00%-Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----319,287-100.00%-Jun 30, 2024
ORBIMED ADVISORS LLC----225,200-100.00%-Jun 30, 2024
DECHENG CAPITAL LLC----195,835-100.00%-Jun 30, 2024
LINCOLN NATIONAL CORP----150,205-100.00%-Jun 30, 2024
EAGLE HEALTH INVESTMENTS LP----135,059-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP----105,261-100.00%-Jun 30, 2024
POINT72 HONG KONG LTD----70,045-100.00%-Jun 30, 2024
D. E. SHAW & CO., INC.----64,799-100.00%-Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----63,400-100.00%-Jun 30, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----53,367-100.00%-Jun 30, 2024
ING GROEP NV----46,400-100.00%-Jun 30, 2024
NEBULA RESEARCH & DEVELOPMENT LLC----40,937-100.00%-Jun 30, 2024
PURA VIDA INVESTMENTS, LLC----38,005-100.00%-Jun 30, 2024
NOMURA HOLDINGS INC----36,000-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----28,200-100.00%-Jun 30, 2024
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP.----23,478-100.00%-Jun 30, 2024
AXQ CAPITAL, LP----23,200-100.00%-Jun 30, 2024
CAPITAL FUND MANAGEMENT S.A.----20,187-100.00%-Jun 30, 2024
NOMURA ASSET MANAGEMENT CO LTD----18,768-100.00%-Jun 30, 2024
TIMESSQUARE CAPITAL MANAGEMENT, LLC----18,670-100.00%-Jun 30, 2024
SWEDBANK AB----17,988-100.00%-Jun 30, 2024
PEARL RIVER CAPITAL, LLC----16,712-100.00%-Jun 30, 2024
TEZA CAPITAL MANAGEMENT LLC----16,351-100.00%-Jun 30, 2024
SEMANTEON CAPITAL MANAGEMENT, LP----15,980-100.00%-Jun 30, 2024
LECAP ASSET MANAGEMENT LTD----14,115-100.00%-Jun 30, 2024
BAYESIAN CAPITAL MANAGEMENT, LP----14,100-100.00%-Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP----13,734-100.00%-Jun 30, 2024
MACKENZIE FINANCIAL CORP----13,405-100.00%-Jun 30, 2024
CAPITAL IMPACT ADVISORS, LLC----13,299-100.00%-Jun 30, 2024
CINCTIVE CAPITAL MANAGEMENT LP----13,234-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----13,121-100.00%-Jun 30, 2024
FOX RUN MANAGEMENT, L.L.C.----12,255-100.00%-Jun 30, 2024
CI PRIVATE WEALTH, LLC----11,547-100.00%-Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----11,012-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----10,827-100.00%-Jun 30, 2024
BRIDGEFRONT CAPITAL, LLC----10,285-100.00%-Jun 30, 2024
NEUBERGER BERMAN GROUP LLC----8,884-100.00%-Jun 30, 2024
BANQUE CANTONALE VAUDOISE----8,404-100.00%-Jun 30, 2024
NEOS INVESTMENT MANAGEMENT LLC----8,341-100.00%-Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC----8,199-100.00%-Jun 30, 2024
ABUNDANCE WEALTH COUNSELORS----7,467-100.00%-Jun 30, 2024
MARYLAND STATE RETIREMENT & PENSION SYSTEM----7,277-100.00%-Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH----6,200-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----5,753-100.00%-Jun 30, 2024
GREEN ALPHA ADVISORS, LLC----5,713-100.00%-Jun 30, 2024
PITCAIRN CO----5,648-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----5,628-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----5,526-100.00%-Jun 30, 2024
INTERCHANGE CAPITAL PARTNERS, LLC----5,411-100.00%-Jun 30, 2024
BRIGHTON JONES LLC----5,395-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----1,531-100.00%-Jun 30, 2024
WALLEYE TRADING LLC----900-100.00%-Jun 30, 2024
INDIANA TRUST & INVESTMENT MANAGEMENT CO----300-100.00%-Jun 30, 2024
HARVEST FUND MANAGEMENT CO., LTD----177-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----106-100.00%-Jun 30, 2024
FIRST MANHATTAN CO. LLC.----11-100.00%-Jun 30, 2024
LIFESTEPS FINANCIAL, INC.----10-100.00%-Jun 30, 2024
RAKUTEN SECURITIES, INC.----10-100.00%-Jun 30, 2024
PRINCETON GLOBAL ASSET MANAGEMENT LLC----9-100.00%-Jun 30, 2024
NORTHWEST INVESTMENT COUNSELORS, LLC----6-100.00%-Jun 30, 2024

10x Genomics's largest sold out institutional shareholder by shares sold is FRESHFORD CAPITAL MANAGEMENT, LLC, sold -0.78M shares, valued at -, as of undefined.

10x Genomics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TAX-MANAGED GROWTH PORTFOLIO1.23%467,079--Mar 31, 2024
SPARROW FUNDS1.23%4,380--Feb 29, 2024
AGF Investments Trust1.17%-22,1024,064-15.53%Mar 31, 2024
Eaton Vance Enhanced Equity Income Fund II0.74%60,525--Mar 31, 2024
Brown Capital Management Mutual Funds0.70%2,105,322452,05727.34%Dec 31, 2023
Ark ETF Trust0.57%4,551,6781,565,20652.41%Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.55%1,816,340402,28428.45%Mar 31, 2024
Alger ETF Trust0.53%3,792--Dec 31, 2023
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.43%402,217--Jan 31, 2024
ALGER FUNDS0.34%326,556289,298776.47%Jan 31, 2024
Tax-Managed Multi-Cap Growth Portfolio0.31%8,214--Jan 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.28%1,009,700478,20089.97%Mar 31, 2024
NB Private Markets Fund III (Master) LLC0.23%136,112--Dec 31, 2023
COLUMBIA ACORN TRUST0.20%653,510--Mar 31, 2024
WANGER ADVISORS TRUST0.20%106,767--Mar 31, 2024
ALGER FUNDS II0.19%43,093--Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.19%1,596,30614,5060.92%Jan 31, 2024
Tema ETF Trust0.18%8,2191,94931.08%Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.16%85,117--Mar 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.14%465,200--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.13%518,761270,640109.08%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.13%350,40010,4003.06%Mar 31, 2024
Voya EQUITY TRUST0.12%180,134179,43325596.72%Feb 29, 2024
Voya VARIABLE PRODUCTS TRUST0.12%42,98414,86552.86%Mar 31, 2024
Ark Venture Fund0.11%10,9824,14560.63%Jan 31, 2024
EntrepreneurShares Series Trust0.11%29,9421,0233.54%Dec 31, 2023
NEW ECONOMY FUND0.11%506,771--Feb 29, 2024
PRUDENTIAL JENNISON MID-CAP GROWTH FUND, INC.0.10%194,592--Feb 29, 2024
BlackRock Health Sciences Trust II0.09%231,9357420.32%Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.06%4,058,91674,3651.87%Feb 29, 2024
PARNASSUS FUNDS0.06%93,160--Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.06%520,10027,8005.65%Jan 31, 2024
Humankind Benefit Corp0.06%1,34512610.34%Dec 31, 2023
BlackRock Health Sciences Trust0.06%15,123570.38%Mar 31, 2024
RENAISSANCE CAPITAL GREENWICH FUNDS0.06%41,072--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.05%88,47620,78030.70%Mar 31, 2024
MASTER ADVANTAGE SMID CAP LLC0.05%6,620--Dec 31, 2020
ALGER PORTFOLIOS0.05%19,36511,662151.40%Dec 31, 2023
LORD ABBETT RESEARCH FUND INC0.05%44,784--Feb 29, 2024
T. Rowe Price Equity Funds, Inc.0.04%474,095242,800104.97%Mar 31, 2024
ALLSPRING VARIABLE TRUST0.04%25,600--Mar 31, 2024
BlackRock Innovation & Growth Trust0.04%42,879--Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.04%196,676--Mar 31, 2024
AMERICAN FUNDS FUNDAMENTAL INVESTORS0.04%764,140--Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.04%76,225--Feb 29, 2024
ALGER INSTITUTIONAL FUNDS0.03%8,8524,998129.68%Jan 31, 2024
TOUCHSTONE FUNDS GROUP TRUST0.03%696,927-29,903-4.11%Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.03%763,117-41,054-5.11%Feb 29, 2024
Calvert Responsible Index Series, Inc.0.03%42,233--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.02%197,752-44,402-18.34%Mar 31, 2024
FIDELITY TREND FUND0.02%14,600--Mar 31, 2024
Fidelity Commonwealth Trust II0.02%138,696-5,600-3.88%Aug 31, 2023
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0.02%140,000--Mar 31, 2024
VANGUARD INDEX FUNDS0.02%8,277,076-1,460,002-14.99%Mar 31, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.02%581,424--Mar 31, 2024
MERIDIAN FUND INC0.02%42,978--Mar 28, 2024
Vanguard Montgomery Funds0.02%4,309--Mar 31, 2024
Fidelity Central Investment Portfolios LLC0.01%769,900134,90021.24%Mar 31, 2024
DELAWARE VIP TRUST0.01%53,504--Mar 28, 2024
TOCQUEVILLE TRUST0.01%2,000--Jan 31, 2024
EATON VANCE SPECIAL INVESTMENT TRUST0.01%23,657--Mar 31, 2024
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.01%30,568--Mar 31, 2024
Morgan Stanley Insight Fund0.01%184,37549,13136.33%Mar 31, 2024
MORGAN STANLEY INSTITUTIONAL FUND INC0.01%804,33373,25610.02%Mar 31, 2024
SHELTON FUNDS0.01%19,300--Feb 29, 2024
FIDELITY CAPITAL TRUST0.01%125,7009,6108.28%Jan 31, 2024
MASTER LARGE CAP SERIES LLC0.01%10,135--Mar 31, 2022
SMALLCAP WORLD FUND INC0.01%793,300--Mar 31, 2024
PIONEER SERIES TRUST II0.01%130,635--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,501--Mar 31, 2024
FIDELITY DESTINY PORTFOLIOS0.01%22,001--Mar 31, 2024
FIDELITY SECURITIES FUND0.01%929,40753,1236.06%Jan 31, 2024
CARILLON SERIES TRUST0.01%536,691--Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.01%71,029--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.01%191,91027,91017.02%Mar 31, 2024
PRUDENTIAL JENNISON SMALL CO FUND, INC.0.01%38,756--Mar 28, 2024
Northern Lights Variable Trust0.01%8,529--Mar 31, 2024
Gabelli Healthcare & WellnessRx Trust0.01%1,000--Dec 29, 2023
FIDELITY COVINGTON TRUST0.01%138,696-20,848-13.07%Mar 31, 2024
AIM SECTOR FUNDS (INVESCO SECTOR FUNDS)0.01%154,333--Jan 31, 2024
John Hancock Exchange-Traded Fund Trust0.01%44,388-299-0.67%Jan 31, 2024
VANGUARD WORLD FUND0.01%1,660,5967,7780.47%Feb 29, 2024
BRIDGEWAY FUNDS INC0.01%15,300--Mar 28, 2024
AB CAP FUND, INC.0.01%221,639--Jan 31, 2024
HUSSMAN INVESTMENT TRUST0.01%21,000--Dec 31, 2023
VANGUARD EXPLORER FUND0.01%71,953--Jan 31, 2024
LEGG MASON PARTNERS VARIABLE EQUITY TRUST0.01%20,700--Dec 29, 2023
FIDELITY COMMONWEALTH TRUST0.00%15,3362481.64%Feb 29, 2024
IndexIQ ETF Trust0.00%10,93510,935-Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%961,07818,4061.95%Feb 29, 2024
FIDELITY CONTRAFUND0.00%296,489--Mar 31, 2024
FIDELITY DEVONSHIRE TRUST0.00%47,000--Jan 31, 2024
FIDELITY PURITAN TRUST0.00%232,811-193,048-45.33%Feb 29, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.00%10,192-5,602-35.47%Mar 31, 2024
MFS SERIES TRUST I0.00%83,508--Feb 29, 2024
Federated Hermes Equity Funds0.00%81,034--Jan 31, 2024
PRIMECAP Odyssey Funds0.00%31,400--Jan 31, 2024
UBS INVESTMENT TRUST0.00%3,158--Feb 29, 2024
EATON VANCE GROWTH TRUST0.00%34,402--Feb 29, 2024
Goldman Sachs ETF Trust II0.00%3,31290.27%Feb 29, 2024

10x Genomics's largest mutual fund holder by % of total assets is "TAX-MANAGED GROWTH PORTFOLIO", owning 467.08K shares, compromising 1.23% of its total assets.

10x Genomics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24127-56.66%
31 Mar, 242935.40%
31 Dec, 232786.11%
30 Sep, 23262-5.07%
30 Jun, 232767.81%
31 Mar, 23256-3.40%
31 Dec, 2226521.56%
30 Sep, 22218-7.23%
30 Jun, 22235-23.70%
31 Mar, 22308-15.15%
31 Dec, 213637.40%
30 Sep, 21338-5.32%
30 Jun, 213578.18%
31 Mar, 213305.10%
31 Dec, 2031437.72%
30 Sep, 2022848.05%
30 Jun, 2015440.00%
31 Mar, 2011022.22%
31 Dec, 1990-2.17%
30 Sep, 1992-
30 Sep, 111-

As of 30 Jun 24, 127 institutions are holding 10x Genomics's shares, representing a decrease of -56.66% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2435,410,006-65.45%
31 Mar, 24102,484,0186.88%
31 Dec, 2395,888,6195.77%
30 Sep, 2390,654,3882.46%
30 Jun, 2388,477,241-1.24%
31 Mar, 2389,592,0153.42%
31 Dec, 2286,632,3070.74%
30 Sep, 2285,997,904-0.04%
30 Jun, 2286,031,4853.96%
31 Mar, 2282,751,5733.53%
31 Dec, 2179,928,8821.49%
30 Sep, 2178,751,9181.10%
30 Jun, 2177,897,7242.56%
31 Mar, 2175,950,34214.69%
31 Dec, 2066,223,380-4.14%
30 Sep, 2069,080,53113.23%
30 Jun, 2061,008,18556.67%
31 Mar, 2038,941,39726.45%
31 Dec, 1930,795,74237.85%
30 Sep, 1922,339,939-
30 Sep, 117,166-

10x Genomics (TXG) has 35.41M shares outstanding as of 30 Jun 24, down -65.45% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2429.66%0.40%
31 Mar, 2485.84%1.31%
31 Dec, 2380.87%1.36%
30 Sep, 2377.00%1.34%
30 Jun, 2375.81%1.26%
31 Mar, 2377.49%1.34%
31 Dec, 2276.09%1.34%
30 Sep, 2275.36%1.31%
30 Jun, 2275.75%1.41%
31 Mar, 2273.25%1.40%
31 Dec, 2172.43%1.44%
30 Sep, 2171.03%1.41%
30 Jun, 2170.90%1.45%
31 Mar, 2169.86%1.83%
31 Dec, 2061.74%1.33%
30 Sep, 2068.17%1.79%
30 Jun, 2061.64%3.81%
31 Mar, 2040.22%3.91%
31 Dec, 1932.07%5.93%
30 Sep, 1923.26%-
30 Sep, 110.01%-

As of 30 Jun 24, 10x Genomics is held by 29.66% institutional shareholders, representing a 0.40% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2469-59.41%
31 Mar, 241709.68%
31 Dec, 2315537.17%
30 Sep, 23113-22.07%
30 Jun, 2314514.17%
31 Mar, 23127-12.41%
31 Dec, 2214528.32%
30 Sep, 22113-8.13%
30 Jun, 22123-30.51%
31 Mar, 22177-11.50%
31 Dec, 2120022.70%
30 Sep, 21163-27.56%
30 Jun, 212258.70%
31 Mar, 21207-7.59%
31 Dec, 2022430.23%
30 Sep, 2017253.57%
30 Jun, 2011253.42%
31 Mar, 207335.19%
31 Dec, 1954-41.30%
30 Sep, 1992-
30 Sep, 111-

69 institutional shareholders have increased their position in TXG stock as of 30 Jun 24 compared to 170 in the previous quarter (a -59.41% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2438-49.33%
31 Mar, 2475-9.64%
31 Dec, 2383-16.16%
30 Sep, 239926.92%
30 Jun, 2378-
31 Mar, 2378-4.88%
31 Dec, 228212.33%
30 Sep, 2273-7.59%
30 Jun, 227911.27%
31 Mar, 2271-32.38%
31 Dec, 211051.94%
30 Sep, 2110330.38%
30 Jun, 2179-7.06%
31 Mar, 218537.10%
31 Dec, 206263.16%
30 Sep, 203872.73%
30 Jun, 202210.00%
31 Mar, 202011.11%
31 Dec, 1918-
30 Sep, 19--
30 Sep, 11--

38 institutional shareholders have reduced their position in TXG stock as of 30 Jun 24 compared to 75 in the previous quarter (a -49.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24127-56.66%35,410,006-65.45%29.66%0.40%69-59.41%38-49.33%
31 Mar, 242935.40%102,484,0186.88%85.84%1.31%1709.68%75-9.64%
31 Dec, 232786.11%95,888,6195.77%80.87%1.36%15537.17%83-16.16%
30 Sep, 23262-5.07%90,654,3882.46%77.00%1.34%113-22.07%9926.92%
30 Jun, 232767.81%88,477,241-1.24%75.81%1.26%14514.17%78-
31 Mar, 23256-3.40%89,592,0153.42%77.49%1.34%127-12.41%78-4.88%
31 Dec, 2226521.56%86,632,3070.74%76.09%1.34%14528.32%8212.33%
30 Sep, 22218-7.23%85,997,904-0.04%75.36%1.31%113-8.13%73-7.59%
30 Jun, 22235-23.70%86,031,4853.96%75.75%1.41%123-30.51%7911.27%
31 Mar, 22308-15.15%82,751,5733.53%73.25%1.40%177-11.50%71-32.38%
31 Dec, 213637.40%79,928,8821.49%72.43%1.44%20022.70%1051.94%
30 Sep, 21338-5.32%78,751,9181.10%71.03%1.41%163-27.56%10330.38%
30 Jun, 213578.18%77,897,7242.56%70.90%1.45%2258.70%79-7.06%
31 Mar, 213305.10%75,950,34214.69%69.86%1.83%207-7.59%8537.10%
31 Dec, 2031437.72%66,223,380-4.14%61.74%1.33%22430.23%6263.16%
30 Sep, 2022848.05%69,080,53113.23%68.17%1.79%17253.57%3872.73%
30 Jun, 2015440.00%61,008,18556.67%61.64%3.81%11253.42%2210.00%
31 Mar, 2011022.22%38,941,39726.45%40.22%3.91%7335.19%2011.11%
31 Dec, 1990-2.17%30,795,74237.85%32.07%5.93%54-41.30%18-
30 Sep, 1992-22,339,939-23.26%-92---
30 Sep, 111-7,166-0.01%-1---

10x Genomics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 23, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell2,936$24.30$71.36K146,203
May 23, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,877$24.30$118.53K889,641
May 23, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell4,087$24.30$99.33K350,055
Mar 06, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,660$44.00$205.02K842,900
Feb 26, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell2,821$46.34$130.74K847,560
Feb 26, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell2,613$46.34$121.10K283,059
Feb 26, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell1,865$46.34$86.43K95,240

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 31, 2024Saxonov Sergedirector, officer Chief Executive OfficerG-GiftSell425--889,216
May 23, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell2,936$24.30$71.36K146,203
May 23, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,877$24.30$118.53K889,641
May 23, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell4,087$24.30$99.33K350,055
Mar 18, 2024Saxonov Sergedirector, officer Chief Executive OfficerG-GiftSell1,086--805,664
Mar 06, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,660$44.00$205.02K842,900
Feb 26, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell2,821$46.34$130.74K847,560
Feb 26, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell2,613$46.34$121.10K283,059
Feb 26, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell1,865$46.34$86.43K95,240

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 02, 2024MATEO ALANdirector-A-AwardBuy21,691--21,691
Jul 19, 2024Teichmann Sarah A.-Buy----
Jun 26, 2024MATEO ALAN-Buy----
Jun 13, 2024STUELPNAGEL JOHN Rdirector-A-AwardBuy8,649--344,250
Jun 13, 2024Kosaraju Sridhardirector-A-AwardBuy8,649--41,092
Jun 13, 2024Popovits Kimberly Jdirector-A-AwardBuy8,649--13,259
Jun 13, 2024SULIMAN SHEHNAAZdirector-A-AwardBuy8,649--13,259
Jun 13, 2024Mammen Mathaidirector-A-AwardBuy8,649--180,259
May 31, 2024Saxonov Sergedirector, officer Chief Executive OfficerG-GiftSell425--889,216
May 23, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell2,936$24.30$71.36K146,203
May 23, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,877$24.30$118.53K889,641
May 23, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell4,087$24.30$99.33K350,055
Mar 25, 2024Saxonov Sergedirector, officer Chief Executive OfficerA-AwardBuy88,854--894,518
Mar 25, 2024Hindson Benjamin J.director, officer See RemarksA-AwardBuy71,083--354,142
Mar 25, 2024McAnear Justin J.officer Chief Financial OfficerA-AwardBuy53,312--148,552
Mar 18, 2024Saxonov Sergedirector, officer Chief Executive OfficerG-GiftSell1,086--805,664
Mar 06, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell4,660$44.00$205.02K842,900
Feb 26, 2024Saxonov Sergedirector, officer Chief Executive OfficerS-SaleSell2,821$46.34$130.74K847,560
Feb 26, 2024Hindson Benjamin J.director, officer See RemarksS-SaleSell2,613$46.34$121.10K283,059
Feb 26, 2024McAnear Justin J.officer Chief Financial OfficerS-SaleSell1,865$46.34$86.43K95,240

The last insider sell of 10x Genomics's stock was made by Saxonov Serge on May 31 2024, selling 425 shares at - per share (valued at -).

10x Genomics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20241--
Q2 202454125.00%
Q1 202431030.00%
Q4 202321315.38%
Q3 202341921.05%
Q2 2023142556.00%
Q1 2023126200.00%
Q4 202221118.18%
Q3 202274175.00%
Q2 2022137185.71%
Q1 2022154434.09%
Q4 20212312618.25%
Q3 20211614710.88%
Q2 20212916917.16%
Q1 20212313117.56%
Q4 20203112924.03%
Q3 2020179318.28%
Q2 2020398844.32%
Q1 2020164932.65%
Q4 201955100.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by 10x Genomics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024-3-
Q1 2024-9-
Q4 2023-11-
Q3 2023-14-
Q2 2023-21-
Q1 2023-5-
Q4 2022-8-
Q3 2022-3-
Q2 20222450.00%
Q1 2022-36-
Q4 2021-102-
Q3 2021-130-
Q2 2021-151-
Q1 2021-116-
Q4 2020-94-
Q3 2020-73-
Q2 2020-59-
Q1 2020-33-
Q4 2019---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of 10x Genomics's stocks.

10x Genomics Peer Ownership


TickerCompany
GHGuardant Health, Inc.
VCYTVeracyte, Inc.
TWSTTwist Bioscience Corporation
FATEFate Therapeutics, Inc.
BEAMBeam Therapeutics Inc.

TXG Ownership FAQ


10x Genomics is owned by institutional shareholders (29.66%), insiders (2.18%), and public (68.17%). The largest institutional shareholder of 10x Genomics is FMR LLC (10.90% of total shares) and the top mutual fund owner is TAX-MANAGED GROWTH PORTFOLIO (1.23% of total shares).

10x Genomics's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, ARK INVESTMENT MANAGEMENT LLC, BLACKROCK INC., and NIKKO ASSET MANAGEMENT AMERICAS, INC.. The top five shareholders own together 37.74% of the company's share outstanding.

As of Jun 2024, there are 127 institutional shareholders of 10x Genomics.

FMR LLC owns 13.01M shares of 10x Genomics, representing 10.90% of the company's total shares outstanding, valued at $253.05M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 10.19M shares of 10x Genomics (TXG), compromising 8.53% of the company, valued at $198.18M.

ARK INVESTMENT MANAGEMENT LLC is the third largest holder of 10x Genomics. The company owns 9.31M of the company's shares outstanding (worth $181.15M).